Therapeutic targeting of angiogenesis molecular pathways in angiogenesis-dependent diseases

Asghar Fallah¹, Ali Sadeghinia², Houman Kahroba³, Amin Samadi⁴, Hamid Reza Heidari⁵, Behzad Bradaran⁶, Sirous Zeinali⁷, Ommoleila Molavi⁸

Affiliations

¹ Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran; Biotechnology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran; Department of Pharmaceutical Biotechnology, Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran.
² Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran; Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran.
³ Molecular Medicine Research Centre, Tabriz University of Medical Sciences, Tabriz, Iran; Department of Molecular Medicine, Faculty of Advanced Medical Sciences, Tabriz University of Medical Sciences, Tabriz, Iran.
⁴ Department of Chemical and Materials Engineering, University of Alberta, Edmonton, Canada.
⁵ Department of Pharmaceutical Biotechnology, Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran.
⁶ Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
⁷ Biotechnology Research Center, Pasteur Institute of Iran, Tehran, Iran.
⁸ Biotechnology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran; Department of Pharmaceutical Biotechnology, Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran; Molecular Medicine Research Centre, Tabriz University of Medical Sciences, Tabriz, Iran. Electronic address: omolavi@ualberta.ca.

PMID: 30554116
DOI: 10.1016/j.biopha.2018.12.022

Free article

Review

Therapeutic targeting of angiogenesis molecular pathways in angiogenesis-dependent diseases

Asghar Fallah et al. Biomed Pharmacother. 2019 Feb.

Free article

. 2019 Feb:110:775-785.

doi: 10.1016/j.biopha.2018.12.022. Epub 2018 Dec 13.

Authors

Asghar Fallah¹, Ali Sadeghinia², Houman Kahroba³, Amin Samadi⁴, Hamid Reza Heidari⁵, Behzad Bradaran⁶, Sirous Zeinali⁷, Ommoleila Molavi⁸

Affiliations

¹ Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran; Biotechnology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran; Department of Pharmaceutical Biotechnology, Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran.
² Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran; Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran.
³ Molecular Medicine Research Centre, Tabriz University of Medical Sciences, Tabriz, Iran; Department of Molecular Medicine, Faculty of Advanced Medical Sciences, Tabriz University of Medical Sciences, Tabriz, Iran.
⁴ Department of Chemical and Materials Engineering, University of Alberta, Edmonton, Canada.
⁵ Department of Pharmaceutical Biotechnology, Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran.
⁶ Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
⁷ Biotechnology Research Center, Pasteur Institute of Iran, Tehran, Iran.
⁸ Biotechnology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran; Department of Pharmaceutical Biotechnology, Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran; Molecular Medicine Research Centre, Tabriz University of Medical Sciences, Tabriz, Iran. Electronic address: omolavi@ualberta.ca.

PMID: 30554116
DOI: 10.1016/j.biopha.2018.12.022

Abstract

Angiogenesis is a critical step in the progression of almost all human malignancies and some other life-threatening diseases. Anti-angiogenic therapy is a novel and effective approach for treatment of angiogenesis-dependent diseases such as cancer, diabetic retinopathy, and age-related macular degeneration. In this article, we will review the main strategies developed for anti-angiogenic therapies beside their clinical applications, the major challenges, and the latest advances in the development of anti-angiogenesis-based targeted therapies.

Keywords: Angiogenesis-dependent diseases; Anti-angiogenesis; Anti-angiogenic therapeutics; Cancer; VEGF–VEGFR system receptors.

PubMed Disclaimer

Cited by

Loss of endothelial glucocorticoid receptor promotes angiogenesis via upregulation of Wnt/β-catenin pathway.
Liu B, Zhou H, Zhang T, Gao X, Tao B, Xing H, Zhuang Z, Dardik A, Kyriakides TR, Goodwin JE. Liu B, et al. Angiogenesis. 2021 Aug;24(3):631-645. doi: 10.1007/s10456-021-09773-x. Epub 2021 Mar 2. Angiogenesis. 2021. PMID: 33650028 Free PMC article.
Comparison of the Therapeutic Efficacies of Topical Rivoceranib and Topical Bevacizumab in a Murine Model of Corneal Neovascularization.
Yoon HJ, Woo JM, Ji YS, Yoon KC. Yoon HJ, et al. Medicina (Kaunas). 2019 Nov 7;55(11):729. doi: 10.3390/medicina55110729. Medicina (Kaunas). 2019. PMID: 31703332 Free PMC article.
Oral Side Effects in Patients with Metastatic Renal Cell Carcinoma Receiving the Antiangiogenic Agent Pazopanib-Report of Three Cases.
Papadopoulou E, Vardas E, Tziveleka S, Georgaki M, Kouri M, Katoumas K, Piperi E, Nikitakis NG. Papadopoulou E, et al. Dent J (Basel). 2022 Dec 8;10(12):232. doi: 10.3390/dj10120232. Dent J (Basel). 2022. PMID: 36547048 Free PMC article.
The consequence of endothelial remodelling on the blood spinal cord barrier and nociception.
Younis A, Hardowar L, Barker S, Hulse RP. Younis A, et al. Curr Res Physiol. 2022 Apr 4;5:184-192. doi: 10.1016/j.crphys.2022.03.005. eCollection 2022. Curr Res Physiol. 2022. PMID: 35434652 Free PMC article. Review.
Expression of CD44 (NKI-P1) in oral squamous cell carcinoma associated vascular endothelial cells: A relationship to tumor angiogenesis.
Essa AAM, Deraz EM. Essa AAM, et al. Saudi Dent J. 2022 Jan;34(1):21-26. doi: 10.1016/j.sdentj.2021.09.022. Epub 2021 Sep 27. Saudi Dent J. 2022. PMID: 35068895 Free PMC article.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Therapeutic targeting of angiogenesis molecular pathways in angiogenesis-dependent diseases

Affiliations

Therapeutic targeting of angiogenesis molecular pathways in angiogenesis-dependent diseases

Authors

Affiliations

Abstract

Similar articles

Cited by

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources